Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
J Am Soc Nephrol Mehdi et al. 20: 2641 Angiotensin Receptor Blocker or a Mineralocorticoid Antagonist in Diabetic Nephropathy
Files in this Data Supplement: